Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Vanguard ends merger talks

Vanguard Medica (LSE:VGD) has pulled out of talks with CeNeS Pharmaceuticals (LSE: CEN) (see BioCentury, May 1,

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE